San Francisco, CA, United States of America

Polly M Fordyce

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Polly M Fordyce: Innovator in Spectrally Encoded Microbeads

Introduction

Polly M Fordyce is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biomarker analysis through her innovative work on spectrally encoded microbeads. Her research focuses on developing methods and devices that enhance the preparation and application of these microbeads, which are essential for high-throughput analysis.

Latest Patents

Polly M Fordyce holds a patent for "Spectrally encoded microbeads and methods and devices for making and using same." This patent describes the preparation and utilization of microbeads that contain multiple lanthanide nanoparticles, each with uniquely identifiable spectral codes. These microbeads are instrumental in multiplexing and high-throughput biomarker analysis, showcasing her innovative approach to solving complex problems in the field.

Career Highlights

Fordyce is affiliated with the University of California, where she continues her research and development efforts. Her work has garnered attention for its potential applications in various scientific and medical fields. With her expertise, she has contributed to advancing the understanding and capabilities of biomarker analysis.

Collaborations

Polly M Fordyce has collaborated with notable colleagues, including Brian Cullen Baxter and Joseph L DeRisi. These partnerships have further enriched her research and expanded the impact of her innovations.

Conclusion

Polly M Fordyce is a trailblazer in the field of spectrally encoded microbeads, with a patent that highlights her innovative contributions. Her work at the University of California and collaborations with esteemed colleagues underscore her commitment to advancing biomarker analysis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…